Association between IL28B polymorphism, TNFα and biomarkers of insulin resistance in chronic hepatitis C‐related insulin resistance
- 26 March 2015
- journal article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 22 (11) , 890-896
Abstract
TNFα has been shown to play a role in hepatitis C virus (HCV)-induced insulin resistance (IR). Polymorphism of the IL28B gene that encodes IFN-lambda 3 may be associated with IR through modulation of TNFα. The aim of this study was to investigate the relationship between IL28B rs12979860 genotype, the level of TNFα activation and the degree of IR in patients with chronic hepatitis C. One hundred and thirty-three nondiabetic genotype 1 HCV-infected patients with biopsy proven noncirrhotic hepatitis C were investigated for IR (using HOMA index), IL28B rs12979860 genotype and fasting circulating levels of soluble receptor 1 of TNFα (sTNFR1) and adipokines: leptin, adiponectin and IL-6. The HOMA-IR was positively correlated with serum levels of leptin (r = 0.35, P < 0.0001) and sTNFR1 (r = 0.35, P < 0.0001) but not with IL-6 or adiponectin. IL28B rs12979860 CC genotype was observed in 35% patients. Genotype CC and nongenotype CC patients were similar in terms of HOMA-IR (means 1.6 ± 0.9 vs 1.7 ± 1.4) and had similar circulating levels of sTNFR1 and adipokines. Independent factors associated with IR were ferritin (OR = 1.002, P = 0.02), leptin (OR = 1.06, P = 0.02) and sTNFR1 (OR = 7.9, P = 0.04). This study suggests that in nondiabetic, noncirrhotic, HCV genotype 1-infected patients, there is no relationship between IL28B rs12979860 genotype and HOMA-IR or sTNFR1 level. HCV-related IR may be mediated through TNFα independent of IL28B genotype.Keywords
This publication has 36 references indexed in Scilit:
- Effects of IL28B rs12979860 CC Genotype on Metabolic Profile and Sustained Virologic Response in Patients With Genotype 1 Chronic Hepatitis CClinical Gastroenterology and Hepatology, 2013
- Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis CHepatology, 2012
- Relation of IL28B Gene Polymorphism with Biochemical and Histological Features in Hepatitis C Virus-Induced Liver DiseasePLOS ONE, 2012
- High-Dose Pegylated Interferon-α and Ribavirin in Nonresponder Hepatitis C Patients and Relationship With IL-28B Genotype (SYREN Trial)Gastroenterology, 2011
- Abnormalities of lipid metabolism in hepatitis C virus infectionGut, 2010
- Interferon-Lambda Genotype and Low Serum Low-Density Lipoprotein Cholesterol Levels in Patients With Chronic Hepatitis C InfectionHepatology, 2010
- Reduction of Insulin Resistance With Effective Clearance of Hepatitis C Infection: Results From the HALT-C TrialClinical Gastroenterology and Hepatology, 2010
- Serum adipokine levels predictive of liver injury in non‐alcoholic fatty liver diseaseLiver International, 2009
- Hepatitis C, insulin resistance and diabetes: clinical and pathogenic dataLiver International, 2009
- An Algorithm for the Grading of Activity in Chronic Hepatitis CHepatology, 1996